Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raul Weiss

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Pacing and Clinical Electrophysiology : PACE|April 9, 2020
Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mappingLarry M Baddour, Raul Weiss, George E Mark, et al.
Circulation|August 28, 2013
Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillatorRaul Weiss, Bradley P Knight, Michael R Gold, et al.
Heart Rhythm|June 19, 2017
Role of exercise electrocardiogram to screen for T-wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillatorMuhammad R Afzal, Christopher Evenson, Auroa Badin, et al.
Journal of Cardiovascular Electrophysiology|September 23, 2021
A 10 J shock impedance in sinus rhythm correlates with a 65 J defibrillation impedance during subcutaneous defibrillator implantation using an intermuscular techniqueToshimasa Okabe, Salvatore J Savona, Faisal Matto, et al.
Journal of Atrial Fibrillation|October 7, 2020
Extreme Obesity is Associated with Low Success Rate of Atrial Fibrillation Catheter AblationToshimasa Okabe, Benjamin Buck, Samuel A Hayes, et al.
Heart Rhythm|November 21, 2013
QTc compared to JTc for monitoring drug-induced repolarization changes in the setting of ventricular pacingShane F Tsai, Mahmoud Houmsse, Barrah Dakhil, et al.
Journal of Cardiovascular Electrophysiology|January 23, 2022
Device-related infection associated with increased mortality risk in de novo transvenous implantable cardioverter-defibrillator medicare patientsMikhael F El-Chami, Yiyan Liu, Robert I Griffiths, et al.
Pacing and Clinical Electrophysiology : PACE|May 14, 2018
Anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: Perspectives from the clinical experience of a U.S. panel of physiciansMichael K Essandoh, George E Mark, Johan D Aasbo, et al.
Heart Rhythm|August 9, 2022
Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval StudyMichael R Gold, Johan D Aasbo, Raul Weiss, et al.
Pacing and Clinical Electrophysiology : PACE|November 11, 2018
Comprehensive strategy to reduce the incidence of lead dislodgement for cardiac implantable electronic devicesMuhammad R Afzal, Sarah Horner, Nancy B Matre, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Pacing and Clinical Electrophysiology : PACE|April 9, 2020
Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mappingLarry M Baddour, Raul Weiss, George E Mark, et al.
Circulation|August 28, 2013
Safety and efficacy of a totally subcutaneous implantable-cardioverter defibrillatorRaul Weiss, Bradley P Knight, Michael R Gold, et al.
Heart Rhythm|June 19, 2017
Role of exercise electrocardiogram to screen for T-wave oversensing after implantation of subcutaneous implantable cardioverter-defibrillatorMuhammad R Afzal, Christopher Evenson, Auroa Badin, et al.
Journal of Cardiovascular Electrophysiology|September 23, 2021
A 10 J shock impedance in sinus rhythm correlates with a 65 J defibrillation impedance during subcutaneous defibrillator implantation using an intermuscular techniqueToshimasa Okabe, Salvatore J Savona, Faisal Matto, et al.
Journal of Atrial Fibrillation|October 7, 2020
Extreme Obesity is Associated with Low Success Rate of Atrial Fibrillation Catheter AblationToshimasa Okabe, Benjamin Buck, Samuel A Hayes, et al.
Heart Rhythm|November 21, 2013
QTc compared to JTc for monitoring drug-induced repolarization changes in the setting of ventricular pacingShane F Tsai, Mahmoud Houmsse, Barrah Dakhil, et al.
Journal of Cardiovascular Electrophysiology|January 23, 2022
Device-related infection associated with increased mortality risk in de novo transvenous implantable cardioverter-defibrillator medicare patientsMikhael F El-Chami, Yiyan Liu, Robert I Griffiths, et al.
Pacing and Clinical Electrophysiology : PACE|May 14, 2018
Anesthesia for subcutaneous implantable cardioverter-defibrillator implantation: Perspectives from the clinical experience of a U.S. panel of physiciansMichael K Essandoh, George E Mark, Johan D Aasbo, et al.
Heart Rhythm|August 9, 2022
Infection in patients with subcutaneous implantable cardioverter-defibrillator: Results of the S-ICD Post Approval StudyMichael R Gold, Johan D Aasbo, Raul Weiss, et al.
Pacing and Clinical Electrophysiology : PACE|November 11, 2018
Comprehensive strategy to reduce the incidence of lead dislodgement for cardiac implantable electronic devicesMuhammad R Afzal, Sarah Horner, Nancy B Matre, et al.
Pageof 11